Single-cell T-cell receptor repertoire profiling in dogs.
Journal
Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179
Informations de publication
Date de publication:
22 Apr 2024
22 Apr 2024
Historique:
received:
10
08
2021
accepted:
10
04
2024
medline:
23
4
2024
pubmed:
23
4
2024
entrez:
22
4
2024
Statut:
epublish
Résumé
Spontaneous cancers in companion dogs are robust models of human disease. Tracking tumor-specific immune responses in these models requires reagents to perform species-specific single cell T cell receptor sequencing (scTCRseq). scTCRseq and integration with scRNA data have not been demonstrated on companion dogs with cancer. Here, five healthy dogs, two dogs with T cell lymphoma and four dogs with melanoma are selected to demonstrate applicability of scTCRseq in a cancer immunotherapy setting. Single-cell suspensions of PBMCs or lymph node aspirates are profiled using scRNA and dog-specific scTCRseq primers. In total, 77,809 V(D)J-expressing cells are detected, with an average of 3498 (348 - 5,971) unique clonotypes identified per sample. In total, 29/34, 40/40, 22/22 and 9/9 known functional TRAV, TRAJ, TRBV and TRBJ gene segments are observed respectively. Pseudogene or otherwise defective gene segments are also detected supporting re-annotation of several as functional. Healthy dogs exhibit highly diverse repertoires, T cell lymphomas exhibit clonal repertoires, and vaccine-treated melanoma dogs are dominated by a small number of highly abundant clonotypes. scRNA libraries define large clusters of V(D)J-expressing CD8+ and CD4 + T cells. Dominant clonotypes observed in melanoma PBMCs are predominantly CD8 + T cells, with activated phenotypes, suggesting possible anti-tumor T cell populations.
Identifiants
pubmed: 38649520
doi: 10.1038/s42003-024-06174-w
pii: 10.1038/s42003-024-06174-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
484Informations de copyright
© 2024. The Author(s).
Références
LeBlanc, A. K. et al. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs. Clin. Cancer Res. 27, 3005–3016 (2021).
Regan, D. P. et al. Losartan blocks osteosarcoma-elicited monocyte recruitment, and combined with the kinase inhibitor toceranib, exerts significant clinical benefit in canine metastatic osteosarcoma. Clin. Cancer Res. 28, 662–676 (2022).
pubmed: 34580111
doi: 10.1158/1078-0432.CCR-21-2105
Rebhun, R. B. et al. Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response. J. Immunother. Cancer 10, e004493 (2022).
Burton, J. H. et al. NCI comparative oncology program testing of non-camptothecin indenoisoquinoline topoisomerase i inhibitors in naturally occurring canine lymphoma. Clin. Cancer Res. 24, 5830–5840 (2018).
pubmed: 30061364
pmcid: 6312717
doi: 10.1158/1078-0432.CCR-18-1498
Olin, M. R. et al. Treatment combining CD200 immune checkpoint inhibitor and tumor-Lysate vaccination after surgery for pet dogs with high-grade glioma. Cancers 11, 137 (2019).
Chambers, M. R. et al. Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus. J. Transl. Genet Genom. 5, 423–442 (2021).
pubmed: 35342877
pmcid: 8955901
Omar, N. B. et al. Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas. Neurosurg. Focus 50, E5 (2021).
pubmed: 33524948
pmcid: 8383155
doi: 10.3171/2020.11.FOCUS20844
Saba, C. et al. A comparative oncology study of iniparib defines its pharmacokinetic profile and biological activity in a naturally-occurring canine cancer model. Plos One 11, e0149194 (2016). https://doi.org/10.1371/journal.pone.0149194 .
Paoloni, M. et al. Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma. PLoS One 10, e0129954 (2015).
pubmed: 26091536
pmcid: 4474860
doi: 10.1371/journal.pone.0129954
Paoloni, M. & Khanna, C. Translation of new cancer treatments from pet dogs to humans. Nat. Rev. Cancer 8, 147–156 (2008).
pubmed: 18202698
doi: 10.1038/nrc2273
Valpione, S. et al. Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy. Nat. Cancer 1, 210–221 (2020).
pubmed: 32110781
pmcid: 7046489
doi: 10.1038/s43018-019-0022-x
Baghban, R. et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun. Signal. 18, 1–19 (2020).
doi: 10.1186/s12964-020-0530-4
O’Donnell, J. S., Teng, M. W. L. & Smyth, M. J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151–167 (2019). https://doi.org/10.1038/s41571-018-0142-8 .
Ayers, J. et al. Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines. J. Vet. Diagn. Invest. 33, 261–278 (2021).
pubmed: 33446089
pmcid: 7944434
doi: 10.1177/1040638720985242
Fastrès, A. et al. Characterization of the bronchoalveolar lavage fluid by single cell gene expression analysis in healthy dogs: a promising technique. Front. Immunol. 11, 1707 (2020).
pubmed: 32849601
pmcid: 7406785
doi: 10.3389/fimmu.2020.01707
Chen, D. et al. Single cell atlas for 11 non-model mammals, reptiles and birds. Nat. Commun. 12, 7083 (2021).
pubmed: 34873160
pmcid: 8648889
doi: 10.1038/s41467-021-27162-2
Skidmore, Z. L. et al. Single cell T cell receptor repertoire profiling for dogs. bioRxiv 2021.06.29.450365. Preprint at https://doi.org/10.1101/2021.06.29.450365 (2021).
Skidmore, Z. et al. Single cell TCR sequencing identifies an enriched V(D)J repertoire in canine melanoma. Cancer Genet. 268-269, 39 (2022).
doi: 10.1016/j.cancergen.2022.10.124
Eschke, M., Moore, P. F., Chang, H., Alber, G. & Keller, S. M. Canine peripheral blood TCRαβ T cell atlas: Identification of diverse subsets including CD8A+ MAIT-like cells by combined single-cell transcriptome and V(D)J repertoire analysis. Front. Immunol. 14, 1123366 (2023).
pubmed: 36911660
pmcid: 9995359
doi: 10.3389/fimmu.2023.1123366
Rissetto, K. C. et al. Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy dogs and dogs with osteosarcoma. Vet. Immunol. Immunopathol. 135, 137–145 (2010).
pubmed: 20197202
doi: 10.1016/j.vetimm.2010.02.002
Wu, T. D. et al. Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature 579, 274–278 (2020).
pubmed: 32103181
doi: 10.1038/s41586-020-2056-8
Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251 (2019).
pubmed: 31359002
pmcid: 6689255
doi: 10.1038/s41591-019-0522-3
Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
pubmed: 28091601
pmcid: 5241818
doi: 10.1038/ncomms14049
Schuldt, N. J. & Binstadt, B. A. Dual TCR T cells: Identity crisis or multitaskers? J. Immunol. 202, 637–644 (2019).
pubmed: 30670579
doi: 10.4049/jimmunol.1800904
Wong, M. T. et al. A high-dimensional atlas of human T cell diversity reveals tissue-specific trafficking and cytokine signatures. Immunity 45, 442–456 (2016). https://doi.org/10.1016/j.immuni.2016.07.007 .
Maeda, S. Veterinary immunology: An introduction - by Ian R. Tizard. Veterinary Dermatol. 20, 144–144 (2009). https://doi.org/10.1111/j.1365-3164.2009.00733.x .
Seelig, D. M. et al. Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics. J. Vet. Intern. Med 28, 878–886 (2014).
pubmed: 24655022
pmcid: 4895451
doi: 10.1111/jvim.12343
Muroyama, Y. & Wherry, E. J. Memory T-cell heterogeneity and terminology. Cold Spring Harb. Perspect. Biol. 13, a037929 (2021).
Martin, J. et al. Comprehensive annotation and evolutionary insights into the canine (Canis lupus familiaris) antigen receptor loci. Immunogenetics 70, 223–236 (2018).
pubmed: 28924718
doi: 10.1007/s00251-017-1028-0
Rieder, M. J. et al. Frequency of gene usage and copy number variation within the rearranged immunoglobin heavy-chain Variable locus based on immune repertoire sequencing. Blood 122, 3486–3486 (2013).
doi: 10.1182/blood.V122.21.3486.3486
Volpe, J. M. & Kepler, T. B. Large-scale analysis of human heavy chain V(D)J recombination patterns. Immunome Res. 4, 3 (2008).
pubmed: 18304322
pmcid: 2275228
doi: 10.1186/1745-7580-4-3
Brezinschek, H. P., Brezinschek, R. I. & Lipsky, P. E. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J. Immunol. 155, 190–202 (1995).
pubmed: 7602095
doi: 10.4049/jimmunol.155.1.190
Brezinschek, H. P. et al. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J. Clin. Invest. 99, 2488–2501 (1997).
pubmed: 9153293
pmcid: 508090
doi: 10.1172/JCI119433
Rosner, K. et al. Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes. Immunology 103, 179–187 (2001).
pubmed: 11412305
pmcid: 1783224
doi: 10.1046/j.1365-2567.2001.01220.x
Kitaura, K., Shini, T., Matsutani, T. & Suzuki, R. A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains. BMC Immunol. 17, 38 (2016).
pubmed: 27729009
pmcid: 5059964
doi: 10.1186/s12865-016-0177-5
Radtanakatikanon, A. et al. Topology and expressed repertoire of the Felis catus T cell receptor loci. BMC Genomics 21, 20 (2020).
pubmed: 31906850
pmcid: 6945721
doi: 10.1186/s12864-019-6431-5
Pégorier, P. et al. IMGT® biocuration and comparative study of the T cell receptor beta locus of veterinary species based on TRB. Front. Immunol. 11, 821 (2020).
pubmed: 32431713
pmcid: 7216736
doi: 10.3389/fimmu.2020.00821
Wang, C. et al. A novel canine reference genome resolves genomic architecture and uncovers transcript complexity. Commun. Biol. 4, 185 (2021).
pubmed: 33568770
pmcid: 7875987
doi: 10.1038/s42003-021-01698-x
Dash, P. et al. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature 547, 89–93 (2017).
pubmed: 28636592
pmcid: 5616171
doi: 10.1038/nature22383
Zhang, H. et al. Investigation of antigen-specific T-Cell receptor clusters in human cancers. Clin. Cancer Res. 26, 1359–1371 (2020).
pubmed: 31831563
doi: 10.1158/1078-0432.CCR-19-3249
Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194–1202 (2020).
pubmed: 32341563
pmcid: 7541396
doi: 10.1038/s41587-020-0505-4
Untergasser, A. et al. Primer3: New capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).
pubmed: 22730293
pmcid: 3424584
doi: 10.1093/nar/gks596
Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics 23, 1289–1291 (2007).
pubmed: 17379693
doi: 10.1093/bioinformatics/btm091
Official 10x Genomics Support. Creating a Reference Package with cellranger mkref. https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/advanced/references (2023) .
Giudicelli, V. et al. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res. 34, D781–D784 (2006).
pubmed: 16381979
doi: 10.1093/nar/gkj088
McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: Doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329–337.e4 (2019).
pubmed: 30954475
pmcid: 6853612
doi: 10.1016/j.cels.2019.03.003
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell https://doi.org/10.1016/j.cell.2021.04.048 (2021).
Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163–172 (2019).
pubmed: 30643263
pmcid: 6340744
doi: 10.1038/s41590-018-0276-y
Choi, J. et al. Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans. Nucleic Acids Res. 47, D780–D785 (2019).
pubmed: 30395284
doi: 10.1093/nar/gky1020
Lugli, E., Galletti, G., Boi, S. K. & Youngblood, B. A. Stem, effector, and hybrid states of memory CD8+ T Cells. Trends Immunol. 41, 17–28 (2020).
pubmed: 31810790
doi: 10.1016/j.it.2019.11.004
Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).
pubmed: 26205583
pmcid: 4889009
doi: 10.1038/nri3862
Flemming, A. What’s driving T cell dysfunction? Nat. Rev. Cancer 19, 251 (2019).
pubmed: 30936467
doi: 10.1038/s41568-019-0138-4
Chen, J. et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature 567, 530–534 (2019).
pubmed: 30814732
pmcid: 6546093
doi: 10.1038/s41586-019-0985-x